LONDON, July 17, 2017 - Mapi, the developer of Linguistic Validation and provider of Clinical Outcome Assessments collaborates with YPrime, the clinical research technology provider, to streamline the deployment of validated assessments migrated onto YPrime's eCOA platform.
Mapi Language services and YPrime are leveraging cloud level integrations between technology platforms to establish an operational interface between Mapi's ISO 17100 certified process and YPrime's eCOA platform facilitating Linguistic Validations and direct screenshot reviews.
The collaboration will also bring integration for Mapi to directly develop and validate eCOAs on YPrime's platform eliminating the manual versioning and migrated questionnaire processes for new “born on eCOA” questionnaires. The cloud facilitated integration process helps with migration integrity of paper originated COAs.
"Working with MAPI is part of YPrime's strategy to simplify access and expedite start-up timelines to eCOA implementation for research organizations across the industry," said Mark Maietta, Chief Commercial Officer of YPrime. "We are thrilled about the opportunity to align our advanced platform with the largest provider of Patient-Centered Outcome instruments in this initiative. With established benefits in user experience, data quality and regulatory acceptance of eCOA solutions, I am confident this alliance will accelerate the already-burgeoning eCOA market adoption."
The new process will reduce the Linguistic Validation cycle and accelerate deployment enabling quicker “first patient in” timelines. Additionally, the alliance enables real time collaboration reducing review and correction cycles. The entire process tightly follows Mapi's ISO 17100 Certification and offers multi-language simultaneous development of validated eCOAs on YPrime's eCOA platform.
Press contact: Media@mapigroup.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.